Large volume wearable injectors are devices that are used to deliver high volume of drugs usually in the range of 2 – 50 ml of drug within 2 – 15 minutes. There are many chronic conditions, which require prolonged and continuous drugs delivery and introduction of wearable injectors are one of the achievement in the field of novel drugs delivery systems. Many global pharmaceutical companies are developing biologic therapeutics, which are basically rooted onto monoclonal antibodies for the treatment of autoimmune disorders and immuno-oncology drugs. With the busy lifestyle there is a low possibility of regular intake of drugs through injections, typically weekly, biweekly or monthly by people suffering from various chronic conditions that require constant medication. Wearable injectors offer the perfect solution in terms of portability and precise dosage administration.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/171
Drugs with longer half-lives, the pharma companies need think the pros and cons between injections and auto-injector and less common injections from a wearable injector
According to Vice-President, Corporate Development, Enable Injections, the increased cost to bring a single pharmaceutical drug into market, which is estimated to be around US$ 2.6 billion in 2015, is a huge expenditure for a new developing pharma company and have a greater burden to make the most of revenue and stay ahead of many pharma and medical device competitors. Pioneering products are high risk/high reward, with various companies focusing on developing first-in-class treatments, with only the most effective surviving in the market. The collaboration between various companies makes provides for highly lucrative opportunities for both large volume wearable injectors market and wearable medical devices market.
Adhesive patches injectors the leading product in the large volume wearable injector market
The global large volume wearable injectors market is segmented on the basis of injector, by usage, by injector mechanism, by therapeutic area, by end user, and geography. On the basis of type of injector, the market is divided into, on-body, off body and hand held. On basis of usage, the market is divided into disposable and reusable. On basis of injector mechanism, the market is divided into spring-based, pressurized gas, motor driven, rotary pump and expandable battery. On basis of therapeutic area, the large volume wearable injectors market is divided into oncology, diabetes, cardiovascular, auto-immune disorders, infectious disease and others. On basis of end user, the market is divided into hospitals, home care settings, clinics, and ambulatory surgical centers, and others.
Collaboration of Pharma and Medical Devices companies to Put Large Volume Wearable Injectors Market on high growth trajectory
Regional segmentation of the large volume wearable injector market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America to hold the major chunk of large volume wearable injectors as many medical device and pharma companies combined together has their research and development centers in U.S., which makes early accessibility of advanced technologies and higher penetration of health care services. For instance, Amgen launched a therapeutic product used to deliver the 70mg of drug every week and then the modification of product transformed weekly dose regime to monthly. This can be used with either a Prefilled Syringe or Auto Injector. With advancements in technology, the company developed a wearable injector, which was approved by US FDA and this device is available in the U.S. since 2016. The other factors fueling growth of the large volume wearable injector market are better marketing, efficacy in long term dosage, and predominantly the rising number of patients with chronic long-term disorders.
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/171
Manufacturer’s Landscape Evolution – Becton Dickinson and West Pharma and heading towards the heading towards the pole position in Large Volume Wearable Injectors Market
Key players operating the large volume wearable injectors market include SteadyMed Therapeutics, Inc., Enable Injections, UNILIFE CORPORATION, Insulet Corporation, Sensile Medical AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Bühler Motor GmbH, Ypsomed, Amgen Inc., among others. Major pharma and medical companies in the market are constantly working towards introducing innovative products and lowering production costs as many large volume biologics are still under clinical trials. For instance in June 2016, Ypsomed self-care solution collaborated with Novo Nordisk to develop and provide new dimensions in insulin pump therapy.